Table 2.
Correlation between CD163 expression and clinicopathological parameters (n=48).
| Characteristics | n (%) | CD163 expression | ||
|---|---|---|---|---|
| low | high | P | ||
| Age (years) | 0.039 | |||
| < 50 | 14 (29.1) | 4 | 10 | |
| ≥ 50 | 34 (70.9) | 11 | 23 | |
| TNM stage | 0.002 | |||
| Ⅰ | 15 (31.2) | 9 | 6 | |
| Ⅱ | 20 (41.7) | 8 | 12 | |
| Ⅲ-Ⅳ | 13 (27.1) | 1 | 12 | |
| Ki-67 (%) | 0.473 | |||
| < 14 | 1 (2.1) | 1 | 0 | |
| ≥ 14 | 47 (97.9) | 17 | 30 | |